Pharmacists authorized to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use, or treatment of COVID-19.
Pharmacist authorization to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use or the treatment of COVID-19
Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.
Manufacturers requirement to report and maintain prescription drug prices
Pharmacists authorized to prescribe, dispense, and administer drugs to prevent acquisition of human immunodeficiency virus; pharmacists authorized to order, conduct, and interpret laboratory tests necessary for therapy that uses drugs to prevent acquisition of human immunodeficiency virus.
Pharmacists authorization to prescribe, dispense and administer drugs to prevent the acquisition of human immunodeficiency virus
Definition of prescription amended to allow for patient-specific indications for use, and Board of Pharmacy required to adopt rules relating to prescription drug labeling.
Licensed pharmacists authority to initiate, order and administer vaccines and certain medical and laboratory tests; coverage under medical assistance requirement
Minnesota prescription monitoring program reporting requirements and immunity from liability modified, Minnesota prescription monitoring program access expanded to allow pharmacists or dispensing practitioners to correct errors in program, program funding continued, and money appropriated.
Pharmacist dispensing of prescriptions using an audible container or braille container label for patients who are visually impaired or blind requirement